Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126161161 | 12616116 | 1 | I | 201509 | 20160721 | 20160802 | 20160802 | EXP | CF20160310 | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002362 | VALIDUS | 80.00 | YR | M | Y | 0.00000 | 20160802 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126161161 | 12616116 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, UNK | Y | UNK | 16273 | 20 | MG | TABLET | |||||
| 126161161 | 12616116 | 2 | SS | IRBESARTAN. | IRBESARTAN | 1 | Oral | 150 MG, DAILY | Y | UNK | 0 | 150 | MG | TABLET | |||||
| 126161161 | 12616116 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 200 MG, TID | U | UNK | 0 | 200 | MG | ||||||
| 126161161 | 12616116 | 4 | C | PREVISCAN /00789001/ | FLUINDIONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126161161 | 12616116 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | UNK | 0 | ||||||||||
| 126161161 | 12616116 | 6 | C | CARAFATE | SUCRALFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126161161 | 12616116 | 7 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126161161 | 12616116 | 1 | Product used for unknown indication |
| 126161161 | 12616116 | 2 | Hypertension |
| 126161161 | 12616116 | 3 | Product used for unknown indication |
| 126161161 | 12616116 | 4 | Product used for unknown indication |
| 126161161 | 12616116 | 5 | Product used for unknown indication |
| 126161161 | 12616116 | 6 | Product used for unknown indication |
| 126161161 | 12616116 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126161161 | 12616116 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126161161 | 12616116 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126161161 | 12616116 | 2 | 201509 | 20151001 | 0 | |
| 126161161 | 12616116 | 6 | 201510 | 0 |